Ultrahuman
Ultrahuman designs and sells wearables (Ring Air/Ring PRO, M1 continuous glucose monitor, Home monitor) and Blood Vision blood tests. It sells mainly direct-to-consumer and through retail, with app-based analytics and subscriptions. Sacra estimates FY2026 revenue (year ending March 2026) at about $69M, and management reported a $140M annualized run rate in August 2026. About 800,000 rings had been sold by August 2026. In September 2026 it announced a $70M financing round, reportedly at about a $365M valuation, with investors including Qualcomm Ventures, Labcorp and Alpha Wave.
Funding
Every round, secondary, debt facility or acquisition involving Ultrahuman that AI Lounge tracks, newest first. Latest: Series C on Sep 1, 2026.
Timeline · 2
In the news
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in